Results

Total Results: 11 records

Showing results for "allergy".
Users also searched for: seasonal allergies

1. CAMH Long Doc Template (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax%20Post%20Exposure%20Prophylaxis%20Implementation%20Guide%20v2.0%2020190607.pdf
   June 07, 2019 - reactions. … Based on the type and severity of a previous allergic reaction, the clinician might want to consider … There is a reminder to ask about allergies to assess the type and severity of the allergic reaction … Verify completeness “confirm allergy status” The provider should evaluate all allergies to determine … Based on the type and severity of the allergic reaction, the antimicrobial might not be absolutely

2. CAMH_Template_Long_Instructions (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax_Post_Exposure_Prophylaxis_CDS_Validation_Report.pdf
   October 17, 2018 - If the patient has no allergies, then this Flag resource will be empty. … If the patient has no allergies to latex, then this Flag resource will be empty. … 0.40 Must sum to 1.0 Allergy transition probability: ciprofloxacin allergy 0.15 Allergy transition … probability: doxycycline allergy 0.15 Allergy transition probability: levofloxacin allergy 0.15 … Allergy transition probability: BioThrax® allergy 0.10 Allergy transition probability: latex allergy

3. Clostridium Difficile (C.Diff) Infection Treatment Pathway Updated March 2019 (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/686/Clostridium%20difficile%20(C.diff)%20Infection%20Treatment%20Pathway_updated%20March%202019.pdf
   January 01, 1970 - tapered regimen after completing therapy for fulminant CDI Not fulminant YES, Fulminant Intolerance/allergy … to oral vancomycin Intolerance/allergy to oral vancomycin RECURRENT CDI?

4. Jan-2017-Cholesterol-Wg-Notes (doc file)
   cds.ahrq.gov/sites/default/files/workgroups/216/jan-2017-cholesterol-wg-notes.docx
   January 01, 2017 - considerations surrounding the provision of medication recommendations based on cardiovascular risk: · Allergy … this may pose implementation challenges given current reality. · Sophisticated systems would embed allergy

5. Feb-2017-Cholesterol-Wg-Notes (doc file)
   cds.ahrq.gov/sites/default/files/workgroups/221/feb-2017-cholesterol-wg-notes.docx
   January 01, 2017 - and exceptions should stop the CDS from presenting any interventions, with the exception of statin allergy … Allergies are very rare and side effects can usually be discussed and worked through with the patient

6. Title of document or resource (doc file)
   cds.ahrq.gov/sites/default/files/workgroups/226/mar-2017-cholesterol-wg-notes.docx
   January 01, 2017 - . · Aspirin use to prevent cardiovascular disease: · Consider allergy as additional exclusion. · Consider

7. Implementation Guide: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease (CVD): An Electronic Clinical Quality Measure (eCQM)-derived CDS (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/21/2024_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
   January 01, 2024 - Updated statin allergy value set to include combination drugs containing statins. … Individuals who have an allergy to statin, are receiving palliative or hospice care, who have active … period. 15 eCQM Denominator Exceptions: • Patients with statin-associated muscle symptoms or an allergy … eCQM measure states that the denominator excepts patients with statin-associated muscle symptoms or allergy … The CQL value set and logic differ in that they contain adverse effects, allergies, and intolerances

8. CDS Connect Implementation Guide Draft (doc file)
   cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
   October 01, 2017 - Exclusions that were considered, but not included in CDS logic at this time Consider completeness Statin allergy … physicians felt that providers should determine if a statin is withheld based on these concepts, since allergies … Consider completeness Statin allergy and intolerance Cholesterol Management Work Group physicians felt … that providers should determine if a statin is withheld based on these concepts, since allergies and

9. Implementation Guide: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/26/2024_CDS_Connect_IG_Aspirin_Therapy.pdf
   January 01, 2024 - Patient has allergy or intolerance to aspirin. g. … currently receiving aspirin (at any dose) OR ordered for or receiving palliative care 14 OR aspirin allergy … Verify completeness Exclusion: aspirin allergy Aspirin should not be prescribed to an individual

10. CDS Connect Implementation Guide Draft (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_USPSTF%20Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_Final.docx
    October 01, 2017 - Patient has allergy or intolerance to aspirin. g. Patient has less than 10-year life expectancy. h. … Verify Completeness Exclusion: Aspirin Allergy ASA should not be prescribed to an individual that

11. CDS Connect Implementation Guide Draft (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM_Final.docx
    October 01, 2017 - Individuals with allergy or intolerance to statin medications, who are receiving palliative care, who … DENOMINATOR EXCEPTIONS: Patients with adverse effect, allergy, or intolerance to statin medication.